Research location
Pringy
France
Advertisement
Research activity in Pringy
FranceCureCurrent currently publishes aggregate city-level research activity for this location: 64 trials and 67 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Pringy
64 linked trials · page 1 of 2Long-term Safety and Tolerability of Tozorakimab in Patients With COPD and History of ExacerbationsNCT07566195 · 2026-05-05 · 1 site observation
RECRUITING
Observational Multicenter Study in Patients Receiving Chemotherapy and Amivantamab for Metastatic Non-small Cell Lung CancerNCT07563205 · 2025-11-19 · 1 site observation
RECRUITING
Analysis of the Effectiveness and Safety of Lorlatinib in Untreated ALK-Positive NSCLC Patients in a French Real-World ContextNCT06487078 · 2025-01-20 · 1 site observation
RECRUITING
PROspective Master-protocol for Evaluation of Systemic THErapeutics in Elderly With Thoracic MalignanciesNCT06646471 · 2024-09-26 · 1 site observation
RECRUITING
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary DiseaseNCT06283966 · 2024-02-21 · 1 site observation
RECRUITING
A Prospective Cohort Study to Evaluate Molecular pRognostic Factors and Resistance Mechanisms to Osimertinib in Adjuvant Treatment of Completely Resected pIB-IIIA Non-small Cell Lung Carcinoma With Common EGFR Mutations (L858R and Del19)NCT06053099 · 2024-01-22 · 1 site observation
RECRUITING
ADT +/- Darolutamide in de Novo Metastatic Prostate Cancer Patients With Vulnerable Functional Ability (PEACE6-Vulnerable)NCT04916613 · 2022-04-19 · 1 site observation
RECRUITING
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy ProductsNCT00271180 · 1983-01-01 · 1 site observation
RECRUITING
Treatment in Patients With Advanced Non-Small Cell Lung Carcinoma and Interstitial Lung DiseaseNCT07420439 · 2026-09-15 · 1 site observation
NOT_YET_RECRUITING
Combination of Paclitaxel-bevacizumab ± Atezolizumab in Patients With Advanced NSCLC Progressing After Immunotherapy & ChemotherapyNCT05781308 · 2023-04-26 · 1 site observation
ACTIVE_NOT_RECRUITING
Observational Study in Patients With Previously Unresectable Malignant Pleural Mesothelioma Treated With Nivolumab and Ipilimumab (MESO-IMMUNE)NCT05308966 · 2022-05-03 · 1 site observation
COMPLETED
Treatment With Tucatinib in Patients With an Isolated Brain Progression of a Metastatic Breast CancerNCT05041842 · 2021-12-17 · 1 site observation
ACTIVE_NOT_RECRUITING
PEmbRolizumab verSus chEmotherapy and pEmbrolizumab in Non-small-cell Lung Cancers (NSCLC) With PDL1 ≥ 50 %NCT04547504 · 2020-12-22 · 1 site observation
ACTIVE_NOT_RECRUITING
Study of Evobrutinib in Participants With RMS (evolutionRMS 2)NCT04338061 · 2020-07-02 · 1 site observation
TERMINATED
Prostate-cancer Treatment Using Stereotactic Radiotherapy for Oligometastases Ablation in Hormone-sensitive PatientsNCT04115007 · 2020-06-23 · 1 site observation
ACTIVE_NOT_RECRUITING
Capivasertib+Fulvestrant vs Placebo+Fulvestrant as Treatment for Locally Advanced (Inoperable) or Metastatic HR+/HER2- Breast CancerNCT04305496 · 2020-04-16 · 1 site observation
ACTIVE_NOT_RECRUITING
To Reduce the Use of Chemotherapy in Postmenopausal Patients With ER-positive and HER2-positive Breast Cancer (TOUCH)NCT03644186 · 2019-04-16 · 1 site observation
COMPLETED
Evaluation of the Feasibility and Clinical Relevance of Liquid Biopsy in Patients With Suspicious Metastatic Lung CancerNCT03721120 · 2019-04-10 · 1 site observation
COMPLETED
A Study Investigating the Outcomes and Safety of Atezolizumab Under Real-World Conditions in Patients Treated in Routine Clinical PracticeNCT03782207 · 2019-02-07 · 1 site observation
COMPLETED
IDentification of Factors Predictive of Tofacitinib's Survival in Patient With Rheumatoid ArthritisNCT03981900 · 2019-01-04 · 1 site observation
COMPLETED
Denosumab and Nivolumab Combination As 2d-line Therapy in Stage IV NSC Lung Cancer with Bone Metastases (DENIVOS)NCT03669523 · 2018-11-06 · 1 site observation
COMPLETED
GB001 in Adult Subjects With Moderate to Severe AsthmaNCT03683576 · 2018-10-22 · 1 site observation
COMPLETED
Impact of Pegfilgrastim on Trastuzumab Anti-tumor Effect and ADCC in Operable HER2+ Breast Cancer Breast CancerNCT03571633 · 2018-08-06 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study Comparing Atezolizumab (Anti PD-L1 Antibody) In Combination With Adjuvant Anthracycline/Taxane-Based Chemotherapy Versus Chemotherapy Alone In Patients With Operable Triple-Negative Breast CancerNCT03498716 · 2018-08-02 · 1 site observation
TERMINATED
An Immuno-Therapy Study of Experimental Medication BMS-986205 Given With Nivolumab With or Without Chemotherapy Compared to Chemotherapy in Participants With Previously Untreated Stage IV or Recurrent Non-Small Cell Lung CancerNCT03417037 · 2018-05-24 · 1 site observation
WITHDRAWN
Study to Investigate CSL112 in Subjects With Acute Coronary SyndromeNCT03473223 · 2018-03-21 · 1 site observation
COMPLETED
Nivolumab and Ipilimumab Versus Chimiotherapy in First Line Treatment in PS 2 or Elderly in Advanced NSCLC PatientsNCT03351361 · 2018-02-19 · 1 site observation
COMPLETED
Antiretroviral Treatment Taken 4 Days Per Week Versus Continuous Therapy 7/7 Days Per Week in HIV-1 Infected PatientsNCT03256422 · 2017-09-07 · 1 site observation
COMPLETED
Personalized Therapy Study - Attain Stability Quad Post-Approval StudyNCT04024943 · 2017-08-21 · 1 site observation
ACTIVE_NOT_RECRUITING
Personalized CRT - MPP Post Approval StudyNCT03232944 · 2017-07-05 · 1 site observation
COMPLETED
Quality of Sleep of Patients With Predominant Central Sleep Apnea Syndrome(SAS) Whose EF > 45% Treated by ASVNCT02835638 · 2017-06-26 · 1 site observation
COMPLETED
Descriptive Observational Study ALK-2016-CPHGNCT03718117 · 2017-01-03 · 1 site observation
COMPLETED
Role of Geriatric Intervention in Treatment of Older Patients With Cancer (PREPARE)NCT02704832 · 2016-09-30 · 1 site observation
COMPLETED
A Safety Extension Study With Benralizumab for Asthmatic Adults on Inhaled Corticosteroid Plus Long-acting β2 AgonistNCT02808819 · 2016-06-30 · 1 site observation
COMPLETED
Comparative Study of Fluticasone Furoate(FF)/Umeclidinium Bromide (UMEC)/ Vilanterol (VI) Closed Therapy Versus FF/VI Plus UMEC Open Therapy in Subjects With Chronic Obstructive Pulmonary Disease (COPD)NCT02729051 · 2016-06-29 · 1 site observation
COMPLETED
Evaluation of the Performance of an e-Health SystemNCT02803489 · 2016-04-08 · 2 site observations
TERMINATED
Evaluation of Toujeo Insulin in Type 2 Diabetes Patients Inadequately Control With Their Basal Insulin TreatmentNCT02967237 · 2016-01-04 · 1 site observation
COMPLETED
Evaluation of the Impact of Nurse-led Telephone on Treatment ComplianceNCT02483416 · 2015-11-19 · 1 site observation
TERMINATED
A "Real World" Trial to Determine Efficacy and Health Outcomes of Toujeo Compared to "Standard of Care" Basal Insulins in Insulin Naïve Patients Initiating InsulinNCT02967224 · 2015-11-05 · 1 site observation
COMPLETED
Addition of Aromatase at the Navelbine in Pretreated Metastatic Breast Cancer.NCT02585388 · 2015-10-23 · 2 site observations
TERMINATED
Effectiveness Study of Nivolumab Compared to Chemotherapy in Patients With Relapsed Small-cell Lung CancerNCT02481830 · 2015-09-14 · 1 site observation
COMPLETED
An Observational Study of the Safety of Herceptin Given Subcutaneously in Patients With Early HER2-positive Breast CancerNCT02286362 · 2015-01-14 · 1 site observation
COMPLETED
Management of Cardiogenic Pulmonary Edema (RENAU-OAP)NCT03148847 · 2015-01-01 · 1 site observation
TERMINATED
A Safety Extension Study to Evaluate the Safety and Tolerability of Benralizumab (MEDI-563) in Asthmatic Adults and Adolescents on Inhaled Corticosteroid Plus LABANCT02258542 · 2014-11-19 · 1 site observation
COMPLETED
A Study Comparing the Efficacy, Safety and Tolerability of Fixed Dose Combination (FDC) of FF/UMEC/VI With the FDC of FF/VI and UMEC/VI; Administered Once-daily Via a Dry Powder Inhaler (DPI) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)NCT02164513 · 2014-06-30 · 1 site observation
COMPLETED
A Study of Atezolizumab Compared With Docetaxel in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Failed Platinum-Containing TherapyNCT02008227 · 2014-03-11 · 1 site observation
COMPLETED
Efficacy and Safety of V0111 Cream on Open Cracked Heel in Diabetic Patients With Polyneuropathy.NCT02045199 · 2014-02-01 · 1 site observation
COMPLETED
Therapeutic Strategies in Patients With Non-squamous Non-small Cell Lung Cancer With Brain MetastasesNCT02162537 · 2013-12-01 · 1 site observation
TERMINATED
First Line Metastatic Breast Cancer Treatment (ESMERALDA)NCT01941407 · 2013-11-01 · 1 site observation
COMPLETED
Efficacy and Safety Study of Benralizumab Added to High-dose Inhaled Corticosteroid Plus LABA in Patients With Uncontrolled AsthmaNCT01928771 · 2013-09-19 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.